Neuralink said on Tuesday it has received the FDA’s “breakthrough device” designation for its experimental implant aimed at restoring vision. Called Blindsight, the device “will enable even those who have lost both eyes and their optic nerve to see,” said Neuralink founder Elon Musk. Reuters reports: The FDA’s breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions. It is aimed at speeding up development and review of devices currently under development. Neuralink did not immediately respond to a request seeking details about when it expects the Blindsight device to move into human trials.
“But this one goes to eleven.” — Nigel Tufnel
Working…
